LOXL2 and breast cancer: As the human breast cancer patient data demonstrated a correlation between the proinflammatory cytokine OSM and the collagen crosslinking enzyme LOXL2, we set out to determine whether OSM could promote the expression of LOXL2 at the transcriptional level.